3,4-Dimethylaniline

We are 3,4-Dimethylaniline CAS:95-64-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 95-64-7
Product Name: 3,4-Dimethylaniline
Other Name:
3,4-Dimethylaniline
3,4-Xylidine
3,4-Dimethylbenzenamine
3,4-DitolueneAmine
 
Density: 1.0±0.1 g/cm3
Boiling Point: 228.0±0.0 °C at 760 mmHg
Melting Point: 49-51 °C(lit.)
Molecular Formula: C8H11N
Molecular Weight: 121.180
Flash Point: 98.3±0.0 °C
Exact Mass: 121.089149
PSA: 26.02000
LogP: 1.86
Vapour Pressure: 0.1±0.4 mmHg at 25°C
Index of Refraction: 1.559
Water Solubility: <1 g/L (24 ºC)
 
Specification
Appearance: White crystalline powder
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Pendimethalin CAS: 40487-42-1.
Be used as pesticide intermediate, mainly used in the synthesis of the herbicide Pendimethalin.
Vitamin B2 intermediate, can also be used as dye intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3,4-Dimethylaniline


Related News: The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.Ácido 6-aminopiridina-2-carboxílico CAS:23628-31-1 In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.1,3-bis (2,4-diaminofenoxi) propano 4HCl CAS:74918-21-1 In addition, although the API and intermediate industries are capital-intensive and technology-intensive industries, new competitors are still joining.3-UREIDOPROPYLTRIETHOXYSILANE CAS:116912-64-2;23779-32-0 The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.

Related Products
Product Name
1-(3,4-dichlorophenyl)-1-hydroxyurea View Details
2-Bromo-5-(hydroxy)benzaldehyde View Details
Methyl cyclobutanecarboxylate View Details
2-amino-N-(5-chloropyridin-2-yl)-5-methoxybenzamide manufacturer 4-Trifluoromethylbenzyl chloride manufacturer 1-Carboxy-1-methylethoxyammonium chloride manufacturer 2,4-Difluorobenzoic acid manufacturer 2-Chloro-5-methyl-3-nitropyridine manufacturer